Nov 14 2024 Feedback.
Contents
 
Introduction
Help Videos
Reference Guide
Getting Started
Protein Structure
Molecular Graphics
Slides & ActiveICM
Sequences & Alignments
Protein Modeling
Cheminformatics
Learn and Predict
Docking
Virtual Screening
Molecular Dynamics
Run MD
 MD Restraints
 MD Membrane
 MD VLS
MolScreen
3D Ligand Editor
Tables and Plots
Local Databases
ICM-Scarab
KNIME
Tutorials
FAQs
 
Index
PrevICM User's Guide
15.3 MD of VLS Hitlist
Next

Refining a virtual screening hitlist with molecular dynamics (MD) simulations can be highly beneficial, particularly when assessing the stability and realistic binding behavior of candidate compounds in complex with the target. While initial docking provides a static snapshot of ligand-protein interactions, MD allows for the exploration of dynamic, time-dependent effects, such as conformational flexibility and solvent effects, which are crucial for accurate binding predictions. Through MD, we can observe how ligands adjust within the binding pocket, monitor changes in the protein’s structure, and detect transient interactions that might be missed in docking alone. By refining the hitlist with MD, we can prioritize compounds that not only bind well in static models but also exhibit sustained interactions in a more realistic, fluctuating environment. This extra layer of validation helps improve the reliability of hitlist rankings and reduce the risk of advancing false positives in drug discovery.

To run use the script runMDopenMM which is in /bin directory of the ICM distribution.


icm64 runMDopenMM.icm -w time=5.0 confs=20 -m -rl ligfile=<hitlist>.icb <receptor>.ob
Statistics on RMSD and RTCNN score drift is tabulated.


Prev
MD Membrane
Home
Up
Next
MD Restraints

Copyright© 1989-2020, Molsoft,LLC - All Rights Reserved.
This document contains proprietary and confidential information of Molsoft, LLC.
The content of this document may not be disclosed to third parties, copied or duplicated in any form,
in whole or in part, without the prior written permission from Molsoft, LLC.